Detalhe da pesquisa
1.
CD8+ T cells promote HIV latency by remodeling CD4+ T cell metabolism to enhance their survival, quiescence, and stemness.
Immunity
; 56(5): 1132-1147.e6, 2023 05 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37030290
2.
Immunological approaches to HIV cure.
Semin Immunol
; 51: 101412, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32981836
3.
Inhibition of major histocompatibility complex-I antigen presentation by sarbecovirus ORF7a proteins.
Proc Natl Acad Sci U S A
; 119(41): e2209042119, 2022 10 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-36136978
4.
Publisher Correction: Evidence that CD32a does not mark the HIV-1 latent reservoir.
Nature
; 563(7733): E33, 2018 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-30315222
5.
Selective BCL-XL Antagonists Eliminate Infected Cells from a Primary-Cell Model of HIV Latency but Not from Ex Vivo Reservoirs.
J Virol
; 95(15): e0242520, 2021 07 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-33980597
6.
Integrated Assessment of Viral Transcription, Antigen Presentation, and CD8+ T Cell Function Reveals Multiple Limitations of Class I-Selective Histone Deacetylase Inhibitors during HIV-1 Latency Reversal.
J Virol
; 94(9)2020 04 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-32051267
7.
Establishment of a Novel Humanized Mouse Model To Investigate In Vivo Activation and Depletion of Patient-Derived HIV Latent Reservoirs.
J Virol
; 93(6)2019 03 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-30626677
8.
HLA-C downregulation by HIV-1 adapts to host HLA genotype.
PLoS Pathog
; 14(9): e1007257, 2018 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-30180214
9.
Myeloid Dendritic Cells Induce HIV Latency in Proliferating CD4+ T Cells.
J Immunol
; 201(5): 1468-1477, 2018 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30030324
10.
Evidence that CD32a does not mark the HIV-1 latent reservoir.
Nature
; 561(7723): E20-E28, 2018 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-30232424
11.
HIV latency reversing agents act through Tat post translational modifications.
Retrovirology
; 15(1): 36, 2018 05 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-29751762
12.
HIV integration and the establishment of latency in CCL19-treated resting CD4(+) T cells require activation of NF-κB.
Retrovirology
; 13(1): 49, 2016 07 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-27459960
13.
HIV reservoirs are dominated by genetically younger and clonally enriched proviruses.
bioRxiv
; 2023 Apr 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-37090500
14.
HIV reservoirs are dominated by genetically younger and clonally enriched proviruses.
mBio
; : e0241723, 2023 Nov 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-37971267
15.
Application of a case-control study design to investigate genotypic signatures of HIV-1 transmission.
Retrovirology
; 9: 54, 2012 Jun 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-22731404
16.
Inhibition of major histocompatibility complex-I antigen presentation by sarbecovirus ORF7a proteins.
bioRxiv
; 2022 May 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-35665005
17.
A participant-derived xenograft model of HIV enables long-term evaluation of autologous immunotherapies.
J Exp Med
; 218(7)2021 07 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33988715
18.
HIV-1 diversity considerations in the application of the Intact Proviral DNA Assay (IPDA).
Nat Commun
; 12(1): 165, 2021 01 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33420062
19.
HIV-specific T cell responses reflect substantive in vivo interactions with antigen despite long-term therapy.
JCI Insight
; 6(3)2021 02 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33400687
20.
BCL-2 antagonism sensitizes cytotoxic T cell-resistant HIV reservoirs to elimination ex vivo.
J Clin Invest
; 130(5): 2542-2559, 2020 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32027622